Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Immune Thrombocytopenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00770562
What this trial is testing

A Study Evaluating the Addition of MabThera (Rituximab) to Standard Treatment in Patients With Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Hoffmann-La Roche 103
Post-approval studies (Phase 4)Looking for participantsNCT04518475
What this trial is testing

Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 224
Testing effectiveness (Phase 2)Looking for participantsNCT07017725
What this trial is testing

A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia

Who this might be right for
Chronic Immune Thrombocytopenia
CASI pharmaceuticals, Inc. 75
Testing effectiveness (Phase 2)Study completedNCT00718692
What this trial is testing

Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Immune Thrombocytopenic Purpura
Symphogen A/S 61
Testing effectiveness (Phase 2)Looking for participantsNCT06992128
What this trial is testing

Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 129
Post-approval studies (Phase 4)Not Yet RecruitingNCT07189910
What this trial is testing

Sequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITP

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 150
Large-scale testing (Phase 3)Study completedNCT00351468
What this trial is testing

EXTEND (Eltrombopag Extended Dosing Study)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
Novartis Pharmaceuticals 302
Not applicableLooking for participantsNCT04528355
What this trial is testing

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+2 more
Paul Szabolcs 50
Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Large-scale testing (Phase 3)Ended earlyNCT01433978
What this trial is testing

A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic Thrombocytopenic Purpura)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Eisai Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT05070845
What this trial is testing

Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Pfizer 91
Large-scale testing (Phase 3)WithdrawnNCT05046327
What this trial is testing

Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 Months

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc.
Early research (Phase 1)Not Yet RecruitingNCT07622329
What this trial is testing

A Clinical Study to Evaluate JCXH-213 in the Treatment of Adults With Primary Immune Thrombocytopenia

Who this might be right for
Thrombocytopenic Purpura, Immune
The General Hospital of Western Theater Command 4
Large-scale testing (Phase 3)Study completedNCT01438840
What this trial is testing

Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)

Who this might be right for
Chronic ThrombocytopeniaImmune Thrombocytopenia
Eisai Inc. 49
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07064889
What this trial is testing

The Combination of Upadacitinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 132
Not applicableLooking for participantsNCT06817395
What this trial is testing

Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Massachusetts General Hospital 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT01966367
What this trial is testing

CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation

Who this might be right for
Bone Marrow Failure SyndromeSevere Aplastic AnemiaSevere Congenital Neutropenia+13 more
Diane George 37
Testing effectiveness (Phase 2)Looking for participantsNCT07104565
What this trial is testing

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

Who this might be right for
Immune Thrombocytopenia
Incyte Corporation 56
Large-scale testing (Phase 3)Study completedNCT00508820
What this trial is testing

An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP

Who this might be right for
Idiopathic Thrombocytopenic PurpuraThrombocytopeniaThrombocytopenic Purpura
Amgen 407
Testing effectiveness (Phase 2)UnknownNCT05943691
What this trial is testing

High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

Who this might be right for
ITP - Immune Thrombocytopenia
Shandong University 100
Next Page